All In Biotech

Drug Trial Radar · NCT06703840

Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile Dysfunction

A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erectile Dysfunction

Last checked: Nov 19, 2026Latest source record: Aug 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 156 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

156

Actual

Start

Nov 8, 2024

Primary completion

Jul 19, 2025

Study completion Aug 19, 2025

Sponsor

Lead sponsor
Dicot ABIndustry
Sponsor type
Industry
First posted
Nov 25, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 25 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if the drug LIB-01 works to treat erectile dysfunction in male adults. It will also learn about the safety of the drug LIB-01. The main questions it aims to answer are: * Does the drug LIB-01 improve erectile function in males with erectile dysfunction? * What medical problems do participants have when taking the drug LIB-01? Researchers will compare the drug LIB-01 to a placebo (a look-alike substance that contains no drug) to see if the drug LIB-01 works to treat erectile dysfunction. Participants will: * Take the drug LIB-01 or a placebo every day for 3 days * Visit the clinic every week for 4 weeks, and at 8 weeks, for checkups and tests

Conditions

  • Erectile Dysfunction

Interventions

  • LIB-01Drug

    LIB-01 oral suspension

  • LIB-01 PlaceboDrug

    LIB-01 Placebo oral suspension

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the efficacy of LIB-01 in the treatment of erectile dysfunction (ED).Time frame: 4 weeks

Locations

6 sites in 3 countries. Site status is shown where the registry gives one.

  • Herlev Hospital

    Herlev, Herlev, Denmark

  • Clinical Trial Consultants

    Groningen, Provincie Groningen, Netherlands

  • Clinical Trial Consultants

    Mölndal, Göteborg, Sweden

  • Clinical Trial Consultants

    Linköping, Linköping, Sweden

  • Clinical Trial Consultants

    Solna, Stockholm County, Sweden

  • Clinical Trial Consultants

    Uppsala, Uppsala County, Sweden

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.